The Chemours Company (FRA:2CU)
Germany · Delayed Price · Currency is EUR | Market Cap | 3.00B +103.3% |
| Revenue (ttm) | 5.05B +0.6% |
| Net Income | -355.59M |
| EPS | -2.37 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 13.11 |
| Dividend | 0.30 (1.60%) |
| Ex-Dividend Date | May 15, 2026 |
| Volume | n/a |
| Open | 19.77 |
| Previous Close | 18.68 |
| Day's Range | 19.77 - 19.98 |
| 52-Week Range | 8.13 - 23.65 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 5, 2026 |
About The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that del... [Read more]
News
Forget chips, liquid cooling may be the next big AI trade: these stocks are leading
The rapid expansion of artificial intelligence is creating a new investment opportunity beyond semiconductors and cloud computing as soaring energy demand in data centers drives growing interest in li...
Chemours price target raised to $22 from $17 at JPMorgan
JPMorgan analyst Jeffrey Zekauskas raised the firm’s price target on Chemours (CC) to $22 from $17 and keeps a Neutral rating on the shares.
Chemours price target raised to $30 from $24 at Alembic Global
Alembic Global raised the firm’s price target on Chemours (CC) to $30 from $24 and keeps an Overweight rating on the shares.
Chemours price target raised to $21 from $17 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews raised the firm’s price target on Chemours (CC) to $21 from $17 and keeps an Equal Weight rating on the shares.
Chemours price target raised to $29 from $26 at RBC Capital
RBC Capital raised the firm’s price target on Chemours (CC) to $29 from $26 and keeps an Outperform rating on the shares after its Q1 results and affirmed guidance. Some…
Chemours price target raised to $30 from $29 at UBS
UBS raised the firm’s price target on Chemours (CC) to $30 from $29 and keeps a Buy rating on the shares.
Chemours price target raised to $30 from $25 at Mizuho
Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $30 from $25 and keeps an Outperform rating on the shares.
The Chemours Company Earnings Call Transcript: Q1 2026
First quarter 2026 results surpassed expectations, led by strong TSS and TT segment performance, robust pricing, and disciplined execution. Guidance for the year is reaffirmed, with continued focus on operational reliability, cost control, and balance sheet strength.
The Chemours Company Earnings release: Q1 2026
The Chemours Company released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
The Chemours Company Quarterly report: Q1 2026
The Chemours Company has published its Q1 2026 quarterly earnings report on May 6, 2026.
The Chemours Company Slides: Q1 2026
The Chemours Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Chemours Announces Second Quarter Dividend
WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per sha...
The Chemours Company Reports First Quarter Results
WILMINGTON, Del., May 5, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions...
Chemours price target raised to $30 from $27 at Truist
Truist analyst Peter Osterland raised the firm’s price target on Chemours (CC) to $30 from $27 and keeps a Buy rating on the shares. As the Iran conflict continues to…
Bitget Launchpool adds Canton (CC) with 1.8M in Token Rewards
VICTORIA, Seychelles, April 24, 2026 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), announced the addition of Canton (CC) to Bitget Launchpool and spot market. Spot trading ...
Chemours Announces Dates for First Quarter 2026 Earnings Release and Webcast Conference Call
WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its first quarter 2026 financial result...
Chemours price target raised to $26 from $21 at RBC Capital
RBC Capital analyst Arun Viswanathan raised the firm’s price target on Chemours (CC) to $26 from $21 and keeps an Outperform rating on the shares as part of a broader…
Chemours price target raised to $29 from $23 at UBS
UBS raised the firm’s price target on Chemours (CC) to $29 from $23 and keeps a Buy rating on the shares.
Chemours price target raised to $27 from $21 at Truist
Truist raised the firm’s price target on Chemours (CC) to $27 from $21 and keeps a Buy rating on the shares. Shares of covered TiO2 producers have seen significant momentum…
Chemours price target raised to $25 from $21 at Mizuho
Mizuho raised the firm’s price target on Chemours (CC) to $25 from $21 and keeps an Outperform rating on the shares. The firm adjusted targets in the chemicals and packaging…
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principa...
The Chemours Company Proxy statement: Proxy Filing
The Chemours Company filed a proxy statement on March 10, 2026, providing details for shareholder voting and corporate governance matters.
The Chemours Company Proxy statement: Proxy filing
The Chemours Company filed a proxy statement on March 10, 2026, providing details for shareholder voting and corporate governance matters.
Chemours price target raised to $21 from $17 at Mizuho
Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $21 from $17 and keeps an Outperform rating on the shares.
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034
WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate principal ...